- Home
- AMRX vs DOCN Comparison
AMRX vs DOCN Comparison
Compare AMRX & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- DOCN
- Stock Information
- Founded
- AMRX 2002
- DOCN 2011
- Country
- AMRX United States
- DOCN United States
- Employees
- AMRX N/A
- DOCN N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- DOCN Retail: Computer Software & Peripheral Equipment
- Sector
- AMRX Health Care
- DOCN Technology
- Exchange
- AMRX Nasdaq
- DOCN Nasdaq
- Market Cap
- AMRX 2.5B
- DOCN 2.5B
- IPO Year
- AMRX N/A
- DOCN 2021
- Fundamental
- Price
- AMRX $8.23
- DOCN $27.85
- Analyst Decision
- AMRX Strong Buy
- DOCN Buy
- Analyst Count
- AMRX 4
- DOCN 14
- Target Price
- AMRX $11.50
- DOCN $40.62
- AVG Volume (30 Days)
- AMRX 1.9M
- DOCN 1.6M
- Earning Date
- AMRX 08-08-2025
- DOCN 08-07-2025
- Dividend Yield
- AMRX N/A
- DOCN N/A
- EPS Growth
- AMRX N/A
- DOCN 119.67
- EPS
- AMRX N/A
- DOCN 1.14
- Revenue
- AMRX $2,830,186,000.00
- DOCN $806,588,000.00
- Revenue This Year
- AMRX $9.84
- DOCN $15.19
- Revenue Next Year
- AMRX $7.33
- DOCN $13.99
- P/E Ratio
- AMRX N/A
- DOCN $24.66
- Revenue Growth
- AMRX 13.42
- DOCN 13.21
- 52 Week Low
- AMRX $6.32
- DOCN $25.45
- 52 Week High
- AMRX $9.48
- DOCN $47.02
- Technical
- Relative Strength Index (RSI)
- AMRX 61.71
- DOCN 45.84
- Support Level
- AMRX $8.05
- DOCN $27.09
- Resistance Level
- AMRX $8.24
- DOCN $28.76
- Average True Range (ATR)
- AMRX 0.21
- DOCN 0.91
- MACD
- AMRX 0.03
- DOCN 0.10
- Stochastic Oscillator
- AMRX 90.91
- DOCN 36.41
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.